Maximizing the synergies of your M&A activity

Research provides insights for organizations looking to understand where deal value comes from.

Join our exclusive webcast on Wednesday, September 19, 10:00 a.m. to 11:00 a.m. EDT/3:00 p.m. to 4:00 p.m. BST, as McKinsey partners Andy West and Jeff Rudnicki share McKinsey’s latest research on M&A synergies.
Some mergers and acquisitions can generate outsized economic profits, but it’s vital to identify, quantify, and systematically capture synergies in order to unlock the full potential of transactions. Andy and Jeff will share McKinsey’s latest research on M&A synergies, including an overview of successful acquirers’ winning formula for value creation used by the most successful acquirers. They will also discuss how mergers and acquisitions represent an avenue for companies to generate an outsized share of economic profit and how, by approaching synergy identification, quantification and capture in an ad hoc or a one-size-fits-all way, many buyers fail to unlock the full potential of their transaction.



McKinsey & Company is committed to protecting your information. Your information will be used in accordance with the applicable data privacy law, our internal policies and our privacy policy. As McKinsey is a global organisation, your information may be stored and processed by McKinsey and its affiliates in countries outside your country of residence, but wherever your information is processed, we will handle it with the same care and respect for your privacy.

About the presenters

Senior Partner, Boston

Andy West

Andy leads McKinsey’s Pharmaceuticals and Medical Products Practice and has spent the past 18 years at the firm advising companies on M&A and commercial growth across healthcare, medical devices, and biotechnology. He is also the global leader of McKinsey’s Transactions service line, which includes all facets of mergers, acquisitions, joint ventures, and divestitures

Andy received an MBA, with a concentration in finance and strategy, from the Kellogg School of Management at Northwestern University and a BA in economics (magna cum laude) from Washington University.
Partner, Boston

Jeff Rudnicki

Jeff is a member of McKinsey’s Strategy & Corporate Finance and Healthcare Systems & Services Practices. His current clients include public health systems and large medical-device manufacturers. He has worked on several strategic transformations, including large-scale M&A. Prior to joining McKinsey, Jeff was an economist specializing in the regulatory implications of M&A.